Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
BlossomHill Therapeutics Q2 Loss Widens

BlossomHill Therapeutics Q2 Loss Widens

MT newswireMT newswire2026/09/18 11:42
07:42 AM EDT, 09/18/2026 (MT Newswires) -- BlossomHill Therapeutics (BLSM) reported a Q2 loss on Friday of $8.75 per share, widening from a loss of $5.51 a year earlier. One analyst polled by FactSet expected a GAAP loss of $0.77. The company did not report any revenue for the quarter. Cash and cash equivalents for the quarter ended June 30 totaled $95.4 million, which, together with proceeds from its recent IPO, should be sufficient to fund operations into Q2 2028, the company said.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Meta (META.US) data center's first high-yield bond is oversubscribed more than four times, strong demand drives premium issuance

The first junk bond issuance by the data center division of Meta Platforms attracted demand over four times the transaction size, with its enticing yields drawing in investors.

智通财经2026/09/19 04:11

US stock index adjustments to take effect next Monday: Bloom Energy (BE.US) and Everpure (P.US) to be included in S&P 500, changes also for mid- and small-cap stocks

Bloom Energy, Illumina, and Everpure will be included in the S&P 500 index, while several other companies will be added to the S&P 100, S&P MidCap 400, and S&P SmallCap 600 indices.

智通财经2026/09/19 02:31